Ketogenic Diet Fuels Small Intestine Tumors in Mice

A high-fat, low-carbohydrate ketogenic diet has been shown to promote tumor growth in the small intestine of susceptible mice, according to research published online in Nature on July 15, 2026. The study, which utilized a mouse model, indicates that this dietary approach may inadvertently feed certain types of intestinal cancers.

The findings suggest that individuals with a predisposition to or existing cases of small intestinal tumors might need to reconsider ketogenic diets, which are often adopted for weight loss or other health reasons. The research highlights a complex interaction between diet and cancer biology, specifically within the gastrointestinal tract. While the study was conducted on mice, the implications point towards the need for more personalized dietary recommendations for human cancer patients.

Researchers observed that the ketogenic diet altered the gut microbiome and metabolic pathways in a way that supported tumor proliferation. This metabolic reprogramming by the diet provides a readily available energy source for rapidly dividing cancer cells. The study's authors, whose names were not specified in the publication details, emphasize that while ketogenic diets have shown benefits in other contexts, their impact on specific cancer types warrants further investigation.

This research underscores the importance of tailoring medical and nutritional advice based on an individual's specific health profile and genetic predispositions. The findings published in Nature (doi:10.1038/d41586-026-02039-w) call for a nuanced approach to dietary interventions, particularly for individuals at risk of or diagnosed with gastrointestinal cancers. Future research will likely focus on understanding the precise molecular mechanisms and exploring potential dietary strategies that could inhibit, rather than promote, tumor growth.